bioRxivNeurosciencePreprint
Proteomic signatures of cognitive resilience in LOU/c/Jall rats converge with inverse hippocampal axes of Alzheimer disease.
Lucas GephineiD, Aurélien M. BadinaiD, Sophie CorvaisieriD, Benjamin B. TournieriD, Marianne LégeriD, Thomas FréretiD
Abstract
Why some individuals maintain good level of cognitive performances during aging, others dont or even progress toward Alzheimers disease. We profiled the hippocampal proteome of adult LOU/c/Jall rats, a strain associated with spontaneous cognitive longevity, and compared this proteomic state with a published human hippocampal Alzheimers disease dataset. Because individual protein changes did not survive proteome-wide correction, interpretation was based on convergent pathway-level, cell-type enrichment and cross-species directional analyses. The LOU hippocampus displayed a structured remodeling of mitochondrial, lysosomal, proteostatic and synaptic systems. Oligodendrocyte-associated nuclear-encoded complex I/III components were reduced, whereas neuronal mitochondrial aminoacyl-tRNA synthetases, V-ATPase, SNARE-related proteins and inhibitory-transmission markers were increased. CD200 was markedly reduced, but this occurred without accompanying complement, microglial, astrocytic or inflammatory activation signatures. Cross-species overlay indicated that several LOU-associated axes were directionally opposed to late Alzheimers disease, particularly synaptic vesicle and inhibitory-transmission programs, whereas myelin-associated changes occupied a lower-amplitude and non-inflammatory position along an axis altered in early Alzheimers disease. These findings identify a hippocampal proteomic configuration associated with the LOU resilience phenotype and suggest that successful brain aging and Alzheimers disease may involve opposing states of shared hippocampal molecular systems. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=115 SRC="FIGDIR/small/735140v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@8a1a17org.highwire.dtl.DTLVardef@b7023corg.highwire.dtl.DTLVardef@f3ca20org.highwire.dtl.DTLVardef@15b1b29_HPS_FORMAT_FIGEXP M_FIG C_FIG HIGHLIGHTSO_LIHippocampal proteome of the LOU/c/Jall rat at 3 months profiled by DIA-MS C_LIO_LICoordinated reduction of complex I/III subunits in oligodendrocytes C_LIO_LINeuronal aminoacyl-tRNA synthetases, V-ATPase and SNARE machinery up-regulated C_LIO_LIMarked reduction of CD200 with no inflammatory correlate C_LIO_LILate human AD hippocampal transcriptome moves opposite to adult LOU C_LI
- organism: rat
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- research focus: spatial domain detection
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multiplexed fractionated proteomics reveals synaptic factors associated with cognitive resilience in Alzheimer's Disease
Becky Catherine Carlyle, Savannah E. Kandigian, … Steven Edward Arnold·bioRxiv·Jul 31, 2020
- Stage-specific proteomic signatures of synaptopathy in Alzheimers disease
Tatiana Georgiades, Jessica Griffiths, … Johanna Jackson·bioRxiv·Oct 8, 2026
- Cognition-Associated Protein Structural Changes in a Rat Model of Aging are Related to Reduced Refolding Capacity
Haley E. Tarbox, Audrey Branch, Stephen D. Fried·Science AdvancesPeer-reviewed·Jul 11, 2025
- A synaptic-astrocytic proteomic signature associated with synaptopathy in Alzheimer's Disease
Jessica Griffiths, Eléonore Schneegans, … Johanna Jackson·bioRxiv·Jan 23, 2025
- Mapping the spatial proteomic signature of dorsal and ventral hippocampus in a mouse model of early Alzheimer's disease: changes in synaptic plasticity-related proteins associated with sexual dimorphism
Ana Contreras, Raquel Jiménez‐Herrera, … Lydia Jiménez‐Díaz·bioRxiv·May 8, 2024
- Region-specific proteomic analysis of aging rhesus macaques following chronic glutamate-carboxypeptidase-II (GCPII) inhibition elucidates potential treatment strategies for sporadic Alzheimer's disease
Alexandra D. Steigmeyer, Alexandria S. Battison, … Dibyadeep Datta·Acta Neuropathologica CommunicationsPeer-reviewed·Oct 3, 2026